Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PHVS stock hub

Pharvaris N.V. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PHVSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PHVS

In the news

Latest news · PHVS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-65.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-39.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PHVS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

EUR

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001830487
Company name	Pharvaris N.V.
Country	Switzerland
Country code	US
Cusip	N69605108
Employees	129
Employees Change	21%
Employees Change Percent	19.44
Enterprise value	$1.6B
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-02-05
Isin	NL00150005Y4
Last refreshed	2026-05-10
Market cap	$2B
Market cap category	Small-Cap
Price	$30.09
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	PHVS
Website	https://pharvaris.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.48%
FCF yield	-8.22%
P/B ratio	6.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-206.3M
Net Income Growth Years	0%
Profit Per Employee	$-1.6M
ROA	-35.81
Roa5y	-26.75
ROCE	-62.47
ROE	-65.19
Roe5y	-43.14
ROIC	-39.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	76.03%
Cagr3y	48.16%
Cagr5y	5.87%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$353.9M
Cash	$342.5M
Current Assets	$352.8M
Current Liabilities	$34.9M
Debt	$912,056
Debt Equity	$0
Equity	$318.5M
Interest Coverage	-982.4
Liabilities	$35.4M
Long Term Assets	$1.1M
Long Term Liabilities	$523,757
Net Cash	$341.6M
Net Cash By Market Cap	$17.35
Net Cash Growth	3.94%
Net Debt Equity	$-1.07
Tangible Book Value	$318.5M
Tangible Book Value Per Share	$4.88
WACC	-8.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.11
Net Working Capital	$-25.7M
Quick ratio	10.01
Working Capital	$316.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.51%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	75.97%
200-day SMA	25.16
3Y total return	225.3%
50-day SMA	27.85
50-day SMA vs 200-day SMA	50over200
5Y total return	32.97%
All Time High	42.86
All Time High Change	-29.79%
All Time High Date	2021-02-22
All Time Low	1.77
All Time Low Change	1,600%
All Time Low Date	2022-12-02
ATR	1.53
Beta	-2.33
Beta1y	0.47
Beta2y	0.5
Ch YTD	8.43
High	31.47
High52	31.47
High52 Date	2026-05-08
High52ch	-4.39%
Low	30
Low52	14.59
Low52 Date	2025-05-14
Low52ch	106.31%
Ma50ch	8.03%
Premarket Change Percent	8.02
Premarket Price	$32.06
Premarket Volume	3,116
Price vs 200-day SMA	19.59%
RSI	56.61
RSI Monthly	61.74
RSI Weekly	63.33
Sharpe ratio	1.13x
Sortino ratio	2.13
Total Return	-9.51%
Tr YTD	8.43
Tr1m	8.08%
Tr1w	2.21%
Tr3m	13.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	5
Analyst Price Target Top	$47
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.77
Operating Income	$-199.4M
Price target	$43.2
Price Target Change	$43.57
Price Target Change Top	$56.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,184,449%
Float Percent	53.79%
Net Borrowing	-258,281.6
Shares Insiders	3.27%
Shares Institutions	53.29%
Shares Out	65,407,822
Shares Qo Q	4.6%
Shares Yo Y	9.51%
Short Float	3.2%
Short Ratio	5.4
Short Shares	1.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-184.2M
Average Volume	342,858.25x
Bv Per Share	4.88
CAPEX	$-193,283
Ch1m	8.08
Ch1w	2.21
Ch1y	75.97
Ch3m	13.89
Ch3y	225.3
Ch5y	32.97
Ch6m	39.37
Change	1.38%
Change From Open	-3.77
Close	29.68
Days Gap	5.36
Depreciation Amortization	223,064.2
Dollar Volume	17,229,654.4
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-199.4M
EBITDA	$-199.2M
EPS	$-3.49
F Score	1
FCF	$-161.8M
FCF EV Yield	-9.95x
FCF Per Share	$-2.47
Financing CF	188,572,524
Fiscal Year End	December
Founded	2,015
Income Tax	$2.3M
Investing CF	-193,283
Ipr	50.45
Iprfo	20.36
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-02
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-02
Ma150	26.02
Ma150ch	15.64%
Ma20	29.21
Ma20ch	3%
Net CF	12,857,639
Next Earnings Date	2026-05-22
Open	31.27
Optionable	Yes
Position In Range	6.12
Post Close	30.09
Postmarket Change Percent	1.96
Postmarket Price	$30.68
Ppne	1,650,334.6
Pre Close	29.68
Price Date	2026-05-08
Ptbv Ratio	6.18
Relative Volume	1.67x
Share Based Comp	22,367,493
Tr6m	39.37%
Volume	572,604

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PHVS pay a dividend?

Capital-return profile for this ticker.

Performance

PHVS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PHVS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+53.3%

Float: +53.8% of shares outstanding

Insider ownership

+3.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PHVS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.6

Neutral momentum band

Price vs 200-day MA

+19.6%

50/200-day relationship not available

Beta (5Y)

-2.33

Less volatile than the market

Sharpe ratio

1.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PHVS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PHVS stock rating?

Pharvaris N.V. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PHVS analysis?

The full report lives at /stocks/PHVS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PHVS?

The latest report frames PHVS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PHVS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.